Top Markets
#1 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +581.31%
#2 Phala Phala +62.14%
#3 Bitway Bitway +34.54%
#4 Backpack Backpack +31.50%
#5 ARK ARK +24.97%
#6 Grass Grass +24.01%
#7 Mubarak Mubarak +23.65%
#8 The Black Bull The Black Bull +21.90%
#9 龙虾 (Lobster) 龙虾 (Lobster) +20.97%
#10 PulseChain PulseChain +19.86%
Coin of the day
Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain)
Settings
Language
ENGLISH
Currency
USD
Theme
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Rank in Stocks #492
Operating globally, Becton, Dickinson and Company (BD) is a prominent... Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
Share Price
$183.63
Market Cap
$50.60B
Change (1 day)
2.24%
Change (1 year)
29.34%
Country
US
Trade Becton, Dickinson and Company (BDX)

Category

Healthcare
EPS for Becton, Dickinson and Company (BDX)
EPS as of June 2026 TTM: $3.32
According to Becton, Dickinson and Company latest financial reports and stock price the company's current EPS (TTM) is $3.32. At the end of 2024 the company had a EPS of $5.88 an increase over its 2023 EPS that were of $4.97.
EPS history for Becton, Dickinson and Company from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $3.32 -43.15%
2025 $5.84 -0.68%
2024 $5.88 18.31%
2023 $4.97 -16.19%
2022 $5.93 -14.31%
2021 $6.92 151.64%
2020 $2.75 -30.56%
2019 $3.96 538.71%
2018 $0.62 -86.81%
2017 $4.70 2.40%
2016 $4.59 33.82%
2015 $3.43 -44.05%
2014 $6.13 -7.54%
2013 $6.63 18.60%
2012 $5.59 -2.78%
2011 $5.75 2.31%
2010 $5.62 9.77%
2009 $5.12 11.06%
2008 $4.61 27.00%
2007 $3.63 19.41%
2006 $3.04 5.92%
2005 $2.87 55.14%
2004 $1.85 -13.55%
2003 $2.14 15.68%
2002 $1.85 19.35%
2001 $1.55 0.65%
2000 $1.54 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 $8.85 166.57%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 $6.41 92.93%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH
Medline Inc. Medline Inc.
Medline Inc.
MDLN.US
 - -
US